Medtronic plc - 31 Dec 2023 Form 5 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
10%+ Owner
Signature
/s/ Thomas Osteraas, Assistant Secretary
Issuer symbol
OBIO
Transactions as of
31 Dec 2023
Net transactions value
$0
Form type
5
Filing time
14 Feb 2024, 18:37:19 UTC
Previous filing
01 Feb 2023
Next filing
29 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock Award $0 +869,493 +17% $0.000000 5,868,916 13 Apr 2023 Held by Covidien Group S.a.r.l. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by a subsidiary of the reporting person, which shares were issued as an earnout under the Agreement and Plan of Merger (the "Merger Agreement") dated effective as of July 4, 2022, by and among Orchestra BioMed Holdings, Inc., Health Sciences Acquisitions Corporation 2 ("HSAC2") and HSAC Olympus Merger Sub, Inc. (as amended, the "Merger Agreement").